BASF India Limited (BASF)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 16 July 2026

₹3,700.5 ↓ 25.87% (1Y)

🎯 Key Takeaways

BASF India is undergoing a strategic transformation centered on the demerger of its Agricultural Solutions Business into a separate listed entity, BASIL, with a 1:1 share exchange ratio targeting listing between January-March 2027. This move reflects a broader effort to enhance operational focus and capital allocation efficiency, supported by shareholder approval and prior divestitures such as the sale of BASF India Coatings.
Revenue declined 11.5% QoQ to ₹3,759 in Q3FY25.
⚠️ 1) Execution risk around the timely listing of BASIL between January-March 2027, which depends on regulatory approvals and market conditions. 2) Margi

Market Cap

₹16,687

P/E Ratio

27.2

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About BASF 📊 Interactive Charts

📖 The Story

BASF India is undergoing a strategic transformation centered on the demerger of its Agricultural Solutions Business into a separate listed entity, BASIL, with a 1:1 share exchange ratio targeting listing between January-March 2027. This move reflects a broader effort to enhance operational focus and capital allocation efficiency, supported by shareholder approval and prior divestitures such as the sale of BASF India Coatings. The company is transitioning from a diversified chemical player to a more specialized structure, though near-term financial performance remains under pressure.

📰 What's Happening

In Q3FY26, BASF India completed the sale of its BASF India Coatings subsidiary for INR 230.16 crore, finalizing a transaction initiated in March 2026. Shareholders approved the demerger scheme for the Agricultural Solutions Business at a court meeting on June 24, 2026, paving the way for the creation of BASIL. Management indicated that the new entity is expected to list between January and March 2027, with dividend policy to be clarified post-demerger. The trading window for equity shares will close on July 1, 2026, following the announcement of Q3FY26 financial results on August 4, 2026.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q2FY21	Q3FY21	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	2,460	2,507	3,326	3,360	3,967	4,248	3,759
Operating Profit	588	246	239	270	348	219	190
OPM %	6.5%	9.6%	6.4%	7.3%	7.9%	4.7%	4.5%
Net Profit	413	115	140	161	221	128	104
EPS	₹95.40	₹26.60	₹32.30	₹37.30	₹51.00	₹29.60	₹23.90

Quarterly revenue has declined from a peak of ₹4,248 crore in Q2FY25 to ₹3,759 crore in Q3FY25, reflecting soft demand and pricing pressures in key segments. Operating margins have also trended downward from 7.9% in Q1FY25 to 4.5% in Q3FY25, indicating margin compression despite cost discipline. Net profit and EPS have fallen sharply from ₹221 crore and ₹51 EPS in Q1FY25 to ₹104 crore and ₹23.9 EPS in Q3FY25, suggesting ongoing operational challenges that may be structural or cyclical in nature.

🔮 Management Outlook & What's Next

Management has not provided forward-looking financial guidance in the latest filings, but has emphasized that the demerger of the Agricultural Solutions Business into BASIL is a key strategic priority. The listing of BASIL is expected between January and March 2027, contingent on regulatory and shareholder approvals. Dividend policy will be reassessed post-demerger, signaling a potential shift in capital allocation strategy toward reinvestment or shareholder returns from the newly structured entity.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Solar Industries India Limited	1.57 L Cr	132.3	—	—	—
Pidilite Industries Limited	1.49 L Cr	75.7	—	—	—
SRF Limited	79,723	69.5	—	—	—
Linde India Limited	62,701	141.9	—	—	—
Gujarat Fluorochemicals Limited	40,793	89.6	—	—	—
Navin Fluorine International Limited	35,894	131.5	—	—	—
Himadri Speciality Chemical Limited	30,071	56.6	—	—	—
Deepak Nitrite Limited	24,911	33.3	—	—	—
Atul Limited	20,904	48.8	—	—	—
Tata Chemicals Limited	19,079	-47.1	—	—	—

🔗 Peer Stock Analyses

SOLARINDS PIDILITIND SRF LINDEINDIA FLUOROCHEM

⚠️ Risk Factors

1) Execution risk around the timely listing of BASIL between January-March 2027, which depends on regulatory approvals and market conditions. 2) Margin pressure persists despite cost management efforts, with operating margins declining to 4.5% in Q3FY25, raising concerns about sustainable profitability. 3) Market reception to the demerger remains uncertain, as investor sentiment may be impacted by execution risks and lack of immediate financial contribution from the demerged business. 4) Limited visibility into BASIL’s standalone financials and dividend policy until closer to listing.

📋 Recent Filings

🧠 Analyst's Read

BASF India is in a pivotal transition phase, shifting from a broad-based chemical manufacturer to a more focused structure through the demerger of its Agricultural Solutions Business. While the strategic rationale is clear, near-term financial performance remains weak, with declining margins and profitability. Investors should monitor the progress of the BASIL listing, clarity on dividend policy, and signs of stabilization in core business trends before forming a view on value creation.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on BASF

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-16.

📡 Get AI alerts when BASF files new disclosures

Track BASF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BASF — Free

Free account · 2 AI queries/day